Given previously observed results of Cry on the multidrug-resistant human colon cancer cell line SW620/Ad300 [20] and its possible effects on eIF4A observed by our group [22], we set out to determine Cry’s anticancer and chemosensitizing effect on BT474 cells and the Lap-resistant variants. This evidence concerns the gene CRYL1 and colonic neoplasm.